RenovoRx
RNXT
12 hedge funds and large institutions have $9.64M invested in RenovoRx in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
251% more capital invested
Capital invested by funds: $2.75M → $9.64M (+$6.89M)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
11.18% more ownership
Funds ownership: 12.85% → 24.03% (+11%)
9% more funds holding
Funds holding: 11 → 12 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$3.46M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$3.43M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$121K |
| 4 |
LFAS
Level Four Advisory Services
Dallas,
Texas
|
+$35.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Colony Group
Boston,
Massachusetts
|
-$37K |
| 2 |
ACA
Affinity Capital Advisors
Berkeley,
California
|
-$6.97K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.81K |
| 4 |
Morgan Stanley
New York
|
-$535 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$32 |
RNXT Hedge Fund Activity: Q1 2023 in Review
12 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q1 2023, worth a combined $9.64M — up 251% from $2.75M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new RNXT positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $3.46M. The largest seller was Colony Group, exiting entirely with an estimated $37K sold.
- 12 institutional investors held RenovoRx (RNXT) as of Q1 2023, up from 11 in Q4 2022.
- Funds reported $9.64M of RenovoRx stock for Q1 2023, up 251% quarter-over-quarter.
- 4 funds opened new RenovoRx positions in Q1 2023 and 2 closed out, a net change of +2 holders.
- The largest RenovoRx buyer in Q1 2023 was Armistice Capital, an estimated $3.46M added.
- The largest RenovoRx seller in Q1 2023 was Colony Group, an estimated $37K sold.
Based on aggregated 13F filings for Q1 2023.